Histogenics to lay off all but 1 employee in restructuring – Mass Device
Histogenics(NSDQ:HSGX) said last week that its board of directors approved a restructuring plan that would result in layoffs for all but one of the companys employees. The layoffs include CEO Adam Gridley and COO Stephen Kennedy. Gridley and Kennedy plan to evaluate strategic alternatives for the company in consulting capacities alongside up to four other…